Jaehyung Kim

Dr. Jaehyung Kim


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2018 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
JKJin Hee Kim
Jin Hee Kim
HBHyun Cheol Bae
Hyun Cheol Bae
JKJaehyung Kim
Jaehyung Kim
HLHana Lee
Hana Lee
WRWoo‐In Ryu
Woo‐In Ryu
SSSang Wook Son
Sang Wook Son

19 August 2022 in Molecules and Cells
Verified
Journal Article
Open access
PDF file
MJMuhammad Junaid
Muhammad Junaid
ALAejin Lee
Aejin Lee
JKJaehyung Kim
Jaehyung Kim
TPTae Jun Park
Tae Jun Park
SLSu Bin Lim
Su Bin Lim
Muhammad Junaid, Aejin Lee, Jaehyung Kim, Tae Jun Park, and Su Bin Lim. Mol. Cells 2022;45:610-9. https://doi.org/10.14348/molcells.2022.0036

3 January 2023 in Applied Acoustics
Verified
Journal Article
Closed access
JLJaehyuk Lee
Jaehyuk Lee
JKJaehyung Kim
Jaehyung Kim
YSYujin Shin
Yujin Shin
JJJuhyun Jeon
Juhyun Jeon
YKYeon June Kang
Yeon June Kang
IJInhwa Jung
Inhwa Jung

12 October 2021 in Cancers
Verified
Journal Article
Open access
PDF file
JKJaehyung Kim
Jaehyung Kim
SKSoo Young Kim
Soo Young Kim
SMShi-Xun Ma
Shi-Xun Ma
SKSeok-Mo Kim
Seok-Mo Kim
SSSu-Jin Shin
Su-Jin Shin
SLSu Bin Lim
Su Bin Lim
In most cases, papillary thyroid cancer (PTC) is highly curable and associated with an excellent prognosis. Yet, there are several clinicopathological features that lead to a poor prognosis, underscoring the need for a better genomic strategy to refine prognostication and patient management. We hypothesized that PPARγ targets could be potential markers for better diagnosis and prognosis due to the variants found in PPARG in three pairs of monozygotic twins with PTC. Here, we developed a 10-gene personalized prognostic index, designated PPARGi, based on gene expression of 10 PPARγ targets. Through scRNA-seq data analysis of PTC tissues derived from patients, we found that PPARGi genes were predominantly expressed in macrophages and epithelial cells. Machine learning algorithms showed a near-perfect performance of PPARGi in deciding the presence of the disease and in selecting a small subset of patients with poor disease-specific survival in TCGA-THCA and newly developed merged microarray data (MMD) consisting exclusively of thyroid cancers and normal tissues.